ANI Pharmaceuticals (ANIP)

[Just the facts maam]

Silvr, I believe you are reading it right she is known as being a deal maker. I also believe her experience in IP will benefit ANIP. I agree on her value in deals regarding Libigel.

When you consider ANIP added Renee P. Tannenbaum to the BOD with her experience of being Vice President of Global Partnering at Halozyme, Inc. and Head of Global Customer Excellence at AbbVie, where she was responsible for building commercial capabilities for the organization. I can see a strategy to partner Corti with other drugs to tackle a number of diseases using Halozyme's Enhanze to improve efficacy in administering the combined drugs. Cook's IP and deal making experience will be valuable in such a growth strategy.

I also believe that the Veeva deal will be important in identifying which drug combos to pursue.

JMHO